SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000920465-20-000059
Filing Date
2020-05-04
Accepted
2020-05-04 08:12:54
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-2020q110xq.htm   iXBRL 10-Q 738937
2 EXHIBIT 31.1 exhibit311fy2020q110-q.htm EX-31.1 14668
3 EXHIBIT 32.1 exhibit321fy2020q110-q.htm EX-32.1 8616
9 GRAPHIC ljpc10kimages001a04.jpg GRAPHIC 71155
  Complete submission text file 0000920465-20-000059.txt   3808894

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20200331.xsd EX-101.SCH 30049
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20200331_cal.xml EX-101.CAL 55071
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20200331_def.xml EX-101.DEF 151907
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20200331_lab.xml EX-101.LAB 433484
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20200331_pre.xml EX-101.PRE 248007
25 EXTRACTED XBRL INSTANCE DOCUMENT ljpc-2020q110xq_htm.xml XML 409787
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36282 | Film No.: 20842836
SIC: 2836 Biological Products, (No Diagnostic Substances)